TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
-
* Corresponding authors: Anita Langerød anita.langerod@medisin.uio.no - Stefanie S Jeffrey ssj@stanford.edu
Breast Cancer Research 2007, 9:R30 doi:10.1186/bcr1675
Accesses
- Last 30 days: 109 accesses
- Last year: 1873 accesses
- All time: 10103 accesses
Cited by
BioMed Central: 5 citations
|
Research article
Triple negative breast carcinoma is a prognostic factor in Taiwanese women Che Lin, Su-Yu Chien, Li-Sheng Chen, Shou-Jen Kuo, Tsai-Wang Chang, Dar-Ren Chen BMC Cancer 2009, 9:192 (18 June 2009) |
|
Methodology article
A signature-based method for indexing cell cycle phase distribution from microarray profiles Hideaki Mizuno, Yoshito Nakanishi, Nobuya Ishii, Akinori Sarai, Kunio Kitada BMC Genomics 2009, 10:137 (30 March 2009) |
|
Viewpoint
Regulation of cancer stem cells by p53 D Joseph Jerry, Luwei Tao, Haoheng Yan Breast Cancer Research 2008, 10:304 (29 August 2008) |
|
Research article
Vanessa Dumeaux, Anne-Lise Børresen-Dale, Jan-Ole Frantzen, Merethe Kumle, Vessela N Kristensen, Eiliv Lund Breast Cancer Research 2008, 10:R13 (13 February 2008) |
|
Research article
Yanyuan Wu, Hezla Mohamed, Ram Chillar, Ishrat Ali, Sheila Clayton, Dennis Slamon, Jaydutt V Vadgama Breast Cancer Research 2008, 10:R3 (10 January 2008) Activated Akt (pAkt) overexpression in tumours predicts a lower survival rate in African American and Latina women, suggesting pAkt is a potential therapeutic target for these high risk populations.
|